Skip to main content
Erschienen in: World Journal of Surgery 1/2014

01.01.2014

Management of Early-stage Esophageal Neoplasia (MESEN) Consensus

verfasst von: Alejandro Nieponice, Adolfo E. Badaloni, Blair A. Jobe, Toshitaka Hoppo, Carlos Pellegrini, Vic Velanovich, Gary W. Falk, Kevin Reavis, Lee Swanstrom, Virender K. Sharma, Fabio Nachman, Franco F. Ciotola, Luis E. Caro, Cecilio Cerisoli, Demetrio Cavadas, Luis Durand Figueroa, Daniel Pirchi, Michael Gibson, Santiago Elizalde, Henry Cohen

Erschienen in: World Journal of Surgery | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Treatment of esophageal adenocarcinoma often involves surgical resection. Newer technologies in interventional endoscopy have led to a substantial paradigm shift in the management of early-stage neoplasia in Barrett’s esophagus comprising high-grade dysplasia (HGD), intramucosal carcinoma, and, in some cases, submucosal carcinoma. However, there has been no consensus regarding the indications for esophageal preservation in these cases. In this work, consensus guidelines were established for the management of early-stage esophageal neoplasia considering clinically relevant aspects (age, comorbidities, and social environment) in each scenario.

Methods

Seventeen experts were invited to participate based on their background and clinical expertise at high-volume centers. A questionnaire was created that included four clinical scenarios covering a wide range of situations within HGD and/or early esophageal neoplasia, particularly where controversies are likely to exist. Each of the clinical scenarios was open to discussion subdivided by patient age (20, 50, and 80 s). For each clinical scenario an expert was chosen to defend that position. Each defense triggered a subsequent discussion during a consensus meeting. Conclusions of that discussion together with an accompanying literature analysis allowed experts to confirm or change their original choices and served as the basis for the recommendations stated in this article.

Results

There was 100 % consensus supporting esophageal preservation in patients with HGD, independent of patient age or Barrett’s length. In patients with T1a adenocarcinoma, consensus for preservation was not reached (65 %) for young and middle-aged individuals but was supported for elderly patients (100 %). For T1b adenocarcinoma, consensus was reached for surgical resection (90 %), leaving organ preservation for patients with very low risk of nodal invasion or poor surgical candidates.

Conclusion

Advances in endoscopic imaging and therapy allow for organ preservation in most settings of early-stage neoplasia of the esophagus, provided that the patient understands the implications of this decision.
Literatur
1.
Zurück zum Zitat Luketich JD et al (2003) Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 238(4):486–494 discussion 494–495PubMed Luketich JD et al (2003) Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg 238(4):486–494 discussion 494–495PubMed
2.
Zurück zum Zitat Orringer MB et al (2007) Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg 246(3):363–372 discussion 372–374PubMedCrossRef Orringer MB et al (2007) Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg 246(3):363–372 discussion 372–374PubMedCrossRef
3.
Zurück zum Zitat DeMeester SR (2010) Evaluation and treatment of superficial esophageal cancer. J Gastrointest Surg 14(Suppl 1):S94–S100PubMedCrossRef DeMeester SR (2010) Evaluation and treatment of superficial esophageal cancer. J Gastrointest Surg 14(Suppl 1):S94–S100PubMedCrossRef
4.
Zurück zum Zitat DeMeester SR (2005) Endoscopic mucosal resection and vagal-sparing esophagectomy for high-grade dysplasia and adenocarcinoma of the esophagus. Semin Thorac Cardiovasc Surg 17(4):320–325PubMedCrossRef DeMeester SR (2005) Endoscopic mucosal resection and vagal-sparing esophagectomy for high-grade dysplasia and adenocarcinoma of the esophagus. Semin Thorac Cardiovasc Surg 17(4):320–325PubMedCrossRef
5.
Zurück zum Zitat Amano Y, Kinoshita Y (2008) Barrett esophagus: perspectives on its diagnosis and management in Asian populations. Gastroenterol Hepatol (NY) 4(1):45–53 Amano Y, Kinoshita Y (2008) Barrett esophagus: perspectives on its diagnosis and management in Asian populations. Gastroenterol Hepatol (NY) 4(1):45–53
6.
Zurück zum Zitat Shaheen NJ et al (2004) What is the best management strategy for high grade dysplasia in Barrett’s oesophagus? A cost effectiveness analysis. Gut 53(12):1736–1744PubMedCrossRef Shaheen NJ et al (2004) What is the best management strategy for high grade dysplasia in Barrett’s oesophagus? A cost effectiveness analysis. Gut 53(12):1736–1744PubMedCrossRef
7.
Zurück zum Zitat Bennett C et al (2012) Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 143(2):336–346PubMedCrossRef Bennett C et al (2012) Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 143(2):336–346PubMedCrossRef
8.
Zurück zum Zitat D’Journo XB et al (2008) The esophageal remnant after gastric interposition. Dis Esophagus 21(5):377–388PubMedCrossRef D’Journo XB et al (2008) The esophageal remnant after gastric interposition. Dis Esophagus 21(5):377–388PubMedCrossRef
9.
Zurück zum Zitat Witteman BP et al (2009) Transoral endoscopic inner layer esophagectomy: management of high-grade dysplasia and superficial cancer with organ preservation. J Gastrointest Surg 13(12):2104–2112PubMedCrossRef Witteman BP et al (2009) Transoral endoscopic inner layer esophagectomy: management of high-grade dysplasia and superficial cancer with organ preservation. J Gastrointest Surg 13(12):2104–2112PubMedCrossRef
10.
Zurück zum Zitat Spechler SJ et al (2011) American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology 140(3):1084–1091PubMedCrossRef Spechler SJ et al (2011) American Gastroenterological Association medical position statement on the management of Barrett’s esophagus. Gastroenterology 140(3):1084–1091PubMedCrossRef
11.
Zurück zum Zitat Browman GP (2012) Challenges in knowledge translation: the early years of Cancer Care Ontario’s Program in Evidence-Based Care. Curr Oncol 19(1):27–35PubMedCentralPubMedCrossRef Browman GP (2012) Challenges in knowledge translation: the early years of Cancer Care Ontario’s Program in Evidence-Based Care. Curr Oncol 19(1):27–35PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Stolte M et al (2010) The pattern of invasion of early carcinomas in Barrett’s esophagus is dependent on the depth of infiltration. Pathol Res Pract 206(5):300–304PubMedCrossRef Stolte M et al (2010) The pattern of invasion of early carcinomas in Barrett’s esophagus is dependent on the depth of infiltration. Pathol Res Pract 206(5):300–304PubMedCrossRef
13.
Zurück zum Zitat Goldblum JR (2003) Barrett’s esophagus and Barrett’s-related dysplasia. Mod Pathol 16(4):316–324PubMedCrossRef Goldblum JR (2003) Barrett’s esophagus and Barrett’s-related dysplasia. Mod Pathol 16(4):316–324PubMedCrossRef
14.
Zurück zum Zitat Sharma P (2001) Controversies in Barrett’s esophagus: management of high grade dysplasia. Semin Gastrointest Dis 12(1):26–32PubMed Sharma P (2001) Controversies in Barrett’s esophagus: management of high grade dysplasia. Semin Gastrointest Dis 12(1):26–32PubMed
15.
Zurück zum Zitat Gurski RR et al (2003) Barrett’s esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg 196(5):706–712 discussion 712–713PubMedCrossRef Gurski RR et al (2003) Barrett’s esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features. J Am Coll Surg 196(5):706–712 discussion 712–713PubMedCrossRef
16.
Zurück zum Zitat Levine DS et al (2000) Safety of a systematic endoscopic biopsy protocol in patients with Barrett’s esophagus. Am J Gastroenterol 95(5):1152–1157PubMedCrossRef Levine DS et al (2000) Safety of a systematic endoscopic biopsy protocol in patients with Barrett’s esophagus. Am J Gastroenterol 95(5):1152–1157PubMedCrossRef
17.
Zurück zum Zitat Toyoda H et al (2004) Detection of intestinal metaplasia in distal esophagus and esophagogastric junction by enhanced-magnification endoscopy. Gastrointest Endosc 59(1):15–21PubMedCrossRef Toyoda H et al (2004) Detection of intestinal metaplasia in distal esophagus and esophagogastric junction by enhanced-magnification endoscopy. Gastrointest Endosc 59(1):15–21PubMedCrossRef
18.
Zurück zum Zitat Thomas T et al (2010) High-resolution endoscopy and endoscopic ultrasound for evaluation of early neoplasia in Barrett’s esophagus. Surg Endosc 24(5):1110–1116PubMedCrossRef Thomas T et al (2010) High-resolution endoscopy and endoscopic ultrasound for evaluation of early neoplasia in Barrett’s esophagus. Surg Endosc 24(5):1110–1116PubMedCrossRef
19.
Zurück zum Zitat Shami VM et al (2006) Clinical impact of conventional endosonography and endoscopic ultrasound-guided fine-needle aspiration in the assessment of patients with Barrett’s esophagus and high-grade dysplasia or intramucosal carcinoma who have been referred for endoscopic ablation therapy. Endoscopy 38(2):157–161PubMedCrossRef Shami VM et al (2006) Clinical impact of conventional endosonography and endoscopic ultrasound-guided fine-needle aspiration in the assessment of patients with Barrett’s esophagus and high-grade dysplasia or intramucosal carcinoma who have been referred for endoscopic ablation therapy. Endoscopy 38(2):157–161PubMedCrossRef
20.
Zurück zum Zitat Gananadha S et al (2008) The utility of FDG-PET in the preoperative staging of esophageal cancer. Dis Esophagus 21(5):389–394PubMedCrossRef Gananadha S et al (2008) The utility of FDG-PET in the preoperative staging of esophageal cancer. Dis Esophagus 21(5):389–394PubMedCrossRef
21.
Zurück zum Zitat Semlitsch T et al (2010) A systematic review of the evidence for radiofrequency ablation for Barrett’s esophagus. Surg Endosc 24(12):2935–2943PubMedCrossRef Semlitsch T et al (2010) A systematic review of the evidence for radiofrequency ablation for Barrett’s esophagus. Surg Endosc 24(12):2935–2943PubMedCrossRef
22.
Zurück zum Zitat Pouw RE et al (2008) Successful balloon-based radiofrequency ablation of a widespread early squamous cell carcinoma and high-grade dysplasia of the esophagus: a case report. Gastrointest Endosc 68(3):537–541PubMedCrossRef Pouw RE et al (2008) Successful balloon-based radiofrequency ablation of a widespread early squamous cell carcinoma and high-grade dysplasia of the esophagus: a case report. Gastrointest Endosc 68(3):537–541PubMedCrossRef
23.
Zurück zum Zitat Pouw RE et al (2008) Radiofrequency ablation for total Barrett’s eradication: a description of the endoscopic technique, its clinical results and future prospects. Endoscopy 40(12):1033–1040PubMedCrossRef Pouw RE et al (2008) Radiofrequency ablation for total Barrett’s eradication: a description of the endoscopic technique, its clinical results and future prospects. Endoscopy 40(12):1033–1040PubMedCrossRef
24.
Zurück zum Zitat Krishnan K et al (2012) Radiofrequency ablation for dysplasia in Barrett’s esophagus restores beta-catenin activation within esophageal progenitor cells. Dig Dis Sci 57(2):294–302PubMedCrossRef Krishnan K et al (2012) Radiofrequency ablation for dysplasia in Barrett’s esophagus restores beta-catenin activation within esophageal progenitor cells. Dig Dis Sci 57(2):294–302PubMedCrossRef
25.
26.
Zurück zum Zitat Ganz RA et al (2008) Circumferential ablation of Barrett’s esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc 68(1):35–40PubMedCrossRef Ganz RA et al (2008) Circumferential ablation of Barrett’s esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc 68(1):35–40PubMedCrossRef
27.
Zurück zum Zitat Shaheen NJ et al (2009) Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 360(22):2277–2288PubMedCrossRef Shaheen NJ et al (2009) Radiofrequency ablation in Barrett’s esophagus with dysplasia. N Engl J Med 360(22):2277–2288PubMedCrossRef
28.
Zurück zum Zitat Orman ES, Li N, Shaheen NJ (2013) Efficacy and durability of radiofrequency ablation for Barrett’s esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol 11(10):1245–1255PubMedCrossRef Orman ES, Li N, Shaheen NJ (2013) Efficacy and durability of radiofrequency ablation for Barrett’s esophagus: systematic review and meta-analysis. Clin Gastroenterol Hepatol 11(10):1245–1255PubMedCrossRef
29.
Zurück zum Zitat Orman ES et al (2013) Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett’s esophagus with radiofrequency ablation. Am J Gastroenterol 108(2):187–195 quiz 196PubMedCrossRef Orman ES et al (2013) Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett’s esophagus with radiofrequency ablation. Am J Gastroenterol 108(2):187–195 quiz 196PubMedCrossRef
30.
Zurück zum Zitat Titi M et al (2012) Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett’s esophagus. Gastroenterology 143(3):564–566 e1PubMedCrossRef Titi M et al (2012) Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett’s esophagus. Gastroenterology 143(3):564–566 e1PubMedCrossRef
31.
Zurück zum Zitat Gray NA, Odze RD, Spechler SJ (2011) Buried metaplasia after endoscopic ablation of Barrett’s esophagus: a systematic review. Am J Gastroenterol 106(11):1899–1908 quiz 1909PubMedCentralPubMedCrossRef Gray NA, Odze RD, Spechler SJ (2011) Buried metaplasia after endoscopic ablation of Barrett’s esophagus: a systematic review. Am J Gastroenterol 106(11):1899–1908 quiz 1909PubMedCentralPubMedCrossRef
32.
Zurück zum Zitat Thomas T et al (2011) Length of Barrett’s segment predicts success of extensive endomucosal resection for eradication of Barrett’s esophagus with early neoplasia. Surg Endosc 25(11):3627–3635PubMedCrossRef Thomas T et al (2011) Length of Barrett’s segment predicts success of extensive endomucosal resection for eradication of Barrett’s esophagus with early neoplasia. Surg Endosc 25(11):3627–3635PubMedCrossRef
33.
Zurück zum Zitat Thomas T, Singh R, Ragunath K (2009) Trimodal imaging-assisted endoscopic mucosal resection of early Barrett’s neoplasia. Surg Endosc 23(7):1609–1613PubMedCrossRef Thomas T, Singh R, Ragunath K (2009) Trimodal imaging-assisted endoscopic mucosal resection of early Barrett’s neoplasia. Surg Endosc 23(7):1609–1613PubMedCrossRef
34.
35.
Zurück zum Zitat Nijhawan PK, Wang KK (2000) Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett’s esophagus. Gastrointest Endosc 52(3):328–332PubMedCrossRef Nijhawan PK, Wang KK (2000) Endoscopic mucosal resection for lesions with endoscopic features suggestive of malignancy and high-grade dysplasia within Barrett’s esophagus. Gastrointest Endosc 52(3):328–332PubMedCrossRef
36.
Zurück zum Zitat Pech O, Ell C (2011) Early esophageal cancer: pro-endoscopic resection. Chirurg 82(6):490–494PubMedCrossRef Pech O, Ell C (2011) Early esophageal cancer: pro-endoscopic resection. Chirurg 82(6):490–494PubMedCrossRef
37.
Zurück zum Zitat Groome M et al (2008) Use of oesophageal stress response proteins as potential biomarkers in the screening for Barrett’s oesophagus. Eur J Gastroenterol Hepatol 20(10):961–965PubMedCrossRef Groome M et al (2008) Use of oesophageal stress response proteins as potential biomarkers in the screening for Barrett’s oesophagus. Eur J Gastroenterol Hepatol 20(10):961–965PubMedCrossRef
38.
Zurück zum Zitat Lewis JJ et al (2011) Factors associated with esophageal stricture formation after endoscopic mucosal resection for neoplastic Barrett’s esophagus. Gastrointest Endosc 74(4):753–760PubMedCentralPubMedCrossRef Lewis JJ et al (2011) Factors associated with esophageal stricture formation after endoscopic mucosal resection for neoplastic Barrett’s esophagus. Gastrointest Endosc 74(4):753–760PubMedCentralPubMedCrossRef
39.
Zurück zum Zitat Van Den Eynde M et al (2010) Endoscopic mucosal or submucosal resection of early neoplasia in Barrett’s esophagus after antireflux surgery. Gastrointest Endosc 72(4):855–861CrossRef Van Den Eynde M et al (2010) Endoscopic mucosal or submucosal resection of early neoplasia in Barrett’s esophagus after antireflux surgery. Gastrointest Endosc 72(4):855–861CrossRef
40.
Zurück zum Zitat Inoue H (2001) Endoscopic mucosal resection for the entire gastrointestinal mucosal lesions. Gastrointest Endosc Clin N Am 11(3):459–478PubMed Inoue H (2001) Endoscopic mucosal resection for the entire gastrointestinal mucosal lesions. Gastrointest Endosc Clin N Am 11(3):459–478PubMed
41.
Zurück zum Zitat Nieponice A et al (2009) An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR. Gastrointest Endosc 69(2):289–296PubMedCrossRef Nieponice A et al (2009) An extracellular matrix scaffold for esophageal stricture prevention after circumferential EMR. Gastrointest Endosc 69(2):289–296PubMedCrossRef
42.
Zurück zum Zitat Badylak SF et al (2011) Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold. Tissue Eng Part A 17(11–12):1643–1650PubMedCrossRef Badylak SF et al (2011) Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold. Tissue Eng Part A 17(11–12):1643–1650PubMedCrossRef
43.
44.
Zurück zum Zitat Luketich JD et al (2012) Outcomes after minimally invasive esophagectomy: review of over 1,000 patients. Ann Surg 256(1):95–103PubMedCrossRef Luketich JD et al (2012) Outcomes after minimally invasive esophagectomy: review of over 1,000 patients. Ann Surg 256(1):95–103PubMedCrossRef
45.
Zurück zum Zitat Briez N et al (2011) Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial—the MIRO trial. BMC Cancer 11:310PubMedCentralPubMedCrossRef Briez N et al (2011) Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial—the MIRO trial. BMC Cancer 11:310PubMedCentralPubMedCrossRef
46.
Zurück zum Zitat Safranek PM et al (2010) Review of open and minimal access approaches to oesophagectomy for cancer. Br J Surg 97(12):1845–1853PubMedCrossRef Safranek PM et al (2010) Review of open and minimal access approaches to oesophagectomy for cancer. Br J Surg 97(12):1845–1853PubMedCrossRef
47.
Zurück zum Zitat Nguyen NT et al (2008) Minimally invasive esophagectomy: lessons learned from 104 operations. Ann Surg 248(6):1081–1091PubMedCrossRef Nguyen NT et al (2008) Minimally invasive esophagectomy: lessons learned from 104 operations. Ann Surg 248(6):1081–1091PubMedCrossRef
48.
Zurück zum Zitat Peyre CG et al (2007) Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia. Ann Surg 246(4):665–671 discussion 671–674PubMedCrossRef Peyre CG et al (2007) Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia. Ann Surg 246(4):665–671 discussion 671–674PubMedCrossRef
49.
Zurück zum Zitat Hoppo T, Jobe BA (2013) Endoscopy and role of endoscopic resection in gastric cancer. J Surg Oncol 107(3):243–249PubMedCrossRef Hoppo T, Jobe BA (2013) Endoscopy and role of endoscopic resection in gastric cancer. J Surg Oncol 107(3):243–249PubMedCrossRef
50.
Zurück zum Zitat Takahashi H et al (2010) Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 72(2):255–264 264 e1-2PubMedCrossRef Takahashi H et al (2010) Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 72(2):255–264 264 e1-2PubMedCrossRef
51.
Zurück zum Zitat Ishihara R et al (2008) Local recurrence of large squamous-cell carcinoma of the esophagus after endoscopic resection. Gastrointest Endosc 67(6):799–804PubMedCrossRef Ishihara R et al (2008) Local recurrence of large squamous-cell carcinoma of the esophagus after endoscopic resection. Gastrointest Endosc 67(6):799–804PubMedCrossRef
52.
Zurück zum Zitat Pech O et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 57(9):1200–1206PubMedCrossRef Pech O et al (2008) Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut 57(9):1200–1206PubMedCrossRef
53.
Zurück zum Zitat Dunbar KB, Spechler SJ (2012) The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol 107(6):850–862 quiz 863PubMedCentralPubMedCrossRef Dunbar KB, Spechler SJ (2012) The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review. Am J Gastroenterol 107(6):850–862 quiz 863PubMedCentralPubMedCrossRef
54.
Zurück zum Zitat Rahman AA, Singh R, Sharma P (2013) Management of Barrett’s esophagus. Minerva Gastroenterol Dietol 59(1):13–23PubMed Rahman AA, Singh R, Sharma P (2013) Management of Barrett’s esophagus. Minerva Gastroenterol Dietol 59(1):13–23PubMed
Metadaten
Titel
Management of Early-stage Esophageal Neoplasia (MESEN) Consensus
verfasst von
Alejandro Nieponice
Adolfo E. Badaloni
Blair A. Jobe
Toshitaka Hoppo
Carlos Pellegrini
Vic Velanovich
Gary W. Falk
Kevin Reavis
Lee Swanstrom
Virender K. Sharma
Fabio Nachman
Franco F. Ciotola
Luis E. Caro
Cecilio Cerisoli
Demetrio Cavadas
Luis Durand Figueroa
Daniel Pirchi
Michael Gibson
Santiago Elizalde
Henry Cohen
Publikationsdatum
01.01.2014
Verlag
Springer US
Erschienen in
World Journal of Surgery / Ausgabe 1/2014
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-013-2235-y

Weitere Artikel der Ausgabe 1/2014

World Journal of Surgery 1/2014 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.